Sio Capital Management, LLC Vanda Pharmaceuticals Inc. Transaction History

Sio Capital Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$4.28 - $6.57 $21,023 - $32,271	-4,912 Reduced 4.79%	97,616 $421,000
Q2 2023 Aug 14, 2023	SELL	$5.9 - $6.95 $125,487 - $147,819	-21,269 Reduced 17.18%	102,528 $675,000
Q1 2023 May 12, 2023	SELL	$6.18 - $7.99 $77,423 - $100,098	-12,528 Reduced 9.19%	123,797 $840,000
Q4 2022 Feb 13, 2023	SELL	$6.87 - $10.96 $2.42 Million - $3.86 Million	-352,640 Reduced 72.12%	136,325 $1.01 Million
Q2 2022 Aug 15, 2022	BUY	$9.31 - $11.84 $3.04 Million - $3.87 Million	326,487 Added 200.94%	488,965 $5.33 Million
Q1 2022 May 16, 2022	BUY	$10.84 - $16.55 $1.76 Million - $2.69 Million	162,478 New	162,478 $1.84 Million
Q4 2020 Feb 16, 2021	SELL	$9.77 - $13.81 $2.04 Million - $2.89 Million	-209,205 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$9.32 - $12.02 $606,648 - $782,393	65,091 Added 45.17%	209,205 $2.02 Million
Q2 2020 Aug 14, 2020	SELL	$9.66 - $12.02 $5.57 Million - $6.94 Million	-577,079 Reduced 80.02%	144,114 $1.65 Million
Q1 2020 May 15, 2020	BUY	$7.5 - $16.8 $5.41 Million - $12.1 Million	721,193 New	721,193 $7.47 Million

157

44.9M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $249M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Sio Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sio Capital Management, LLC with notifications on news.